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INTRODUCTION 
Pediatric patients represent a very heterogeneous 
group in need of individualized dosing and ease of 
administration palatable medicines. Small flexible 
drug dosing forms as mini-tablets, might be a 
preferred alternative when formulating new 
dosage forms for children [1].   
Excipients are crucial for the properties of the 
final dosage. Excipients that are innocuous, when 
used in adults may pose a risk to the different age 
groups within the pediatric population [2], 
therefore a complete, universally accepted food 
component used in children’s diet since birth, 
would be an innovative and attractive excipient in 
formulating dosage forms for the pediatric 
population. Due to its rich composition, milk has 
been proposed as a vehicle for physiologically 
active entities [3].  
Paracetamol is accepted as a very effective 
treatment for the relief of pain and fever in adults 
and children. 
The study aims at the assessment of the feasibility 
of using powdered milk to delivery drugs orally to 
children based on a methodology to optimize both 
the process and formulation parameters to lessen 
costs, save time and improve the properties of the 
resulting products. Consequently, it is critical to 
identify the variables that affect the most the 
quality of the product obtained. In this study full 
factorial designs [4] were employed to identify the 
variables (both formulation and processing) and 
their interactions with significant impact on 
selected properties of powders, compacts and 
minitablets made of paracetamol and powder milk 
produced by direct compression. 
  
MATERIALS AND METHODS 
A 2
3 
full factorial design was carried out to 
identify the effect of selected variables and their 
interactions (see, Table 1), on selected responses  
 
 
(weight variation, thickness, tensile strength and 
dissolution time) of the mini-tablets manufac-
tured. 
Tablets were manufactured according to a matrix 
design resulting in eight combinations of four 
different tableting formulations compacted at two 
distinct pressures. Each experiment was carried 
out twice, resulting in a total of 16 different mini-
tablets batches, randomly produced.  
Each tablet batch was evaluated for thickness 
(n=6), uniformity of weight (n=20), diametric 
crushing strength and tensile strength (σ) (n=6) 
and dissolution testing (n=12), were carried out 
accord-ing to Eur. Pharm., when appropriate. 
A stepwise multiple linear regression was  
used to identify and quantify the relationships 
between each response and the variables studied 
and their interactions. Results were analyzed by 
ANOVA in order to identify the significant 
variables and variable interactions responsible for 
the effects observed; the criteria considered to 
accept or reject a variable was based on its 
significance, reflected by the F-value (p< 0.05).  
 
Factor Variables 
Levels 
Low 
(-1) 
High 
(+1)  
Milk/Paraetamol 
ratio 
m/M 20/80 80/20 
Disintegrant (%) d/D 1 5 
Compression 
pressure (GPa) 
f/F 73 178 
Table 1. Independent variables and their levels in 
the full factorial design 
 
 
RESULTS AND DISCUSSION 
The increase on milk fraction in the formulation 
improved the compressibility of paracetamol with 
a decrease on weight variation. Thinner and 
harder compacts with slower paracetamol releases 
were obtained. These observations were not 
surprising if powdered milk composition is taken 
into consideration: milk proteins, lactose (widely 
used as diluent) and lipids (often used as binders 
and taste masking agents), which individually or 
in combination contribute to easier the production 
of tablets. 
A marked decrease on the dissolution time 
(approx. 50%) was observed as sodium 
croscarmellose was added to the milk rich 
formulations. These findings are in good 
agreement with the expected use of sodium 
croscarmellose. 
The increase of the compaction force was 
reflected by the production of thinner compacts 
with slightly higher tensile strengths but random 
effect on the dissolution median time. Mechanical 
strength increases by a power function with 
increasing pressure, but at high pressures it is 
often observed and expected that the crushing 
strength levels off. Another phenomenon 
occurring at high pressure is the increase impor-
tance of particle deformation in disintegration due 
to hindrance of ﬂuid penetration by further 
reduction of porosity. The former may explain 
why no significant effect was detected when 
analyzing tensile strength and dissolution profile. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Graphical representation of the equations 
for weight variation (a), thickness (b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Graphical representation of the equations 
for tensile strength (a), dissolution test (b). 
 
 
CONCLUSION 
The experimental design and statistical analysis 
enabled the identification of the most significant 
variables and their interactions affecting the 
properties of the mini-tablets, particularly the 
milk/paracetamol ratio which proved to be critical 
for the proprieties of the final An excipient 
intended for direct compression when added to the 
formulation should produce tablets with enough 
tensile strength to withstand handling, a low 
friability, a low weight variation, a short 
disintegration time and a high drug dissolution 
rate, considering the showed results it seems that 
powder milk may be a promising new main 
excipient for the minitablettng of poor 
compressible drugs 
 
REFERENCES 
1. Thomson, S.A., et al., Minitablets: new 
modality to deliver medicines to preschool-
aged children. Pediatrics. 123, 235-238 (2009). 
2. van Riet-Nales, D.A., et al., Acceptability of 
different oral formulations in infants and 
preschool children. Arch Dis Child. 98, 725-31 
(2013). 
3. Livney, Y.D., Milk proteins as vehicles for 
bioactives. Current Opinion in Colloid & 
Interface Science. 15, 73-83. 2010. 
4. Lewis, G.A., D. Mathieu, and R. Phan-Tan-
Luu. Pharmaceutical Experimental Design. 
New York: Marcel Dekker, Inc 512 (1998). 
